HOME >> MEDICINE >> NEWS
Answers To Access, Adherence And Tolerance Of Protease Inhibitors

PROVIDENCE, R.I. - Protease inhibitors - the backbone ingredient of the potent triple therapy drug regimen - may not be performing as well in practice as they did in clinical trials, and some patients who could benefit from them may not be receiving them, according to three studies about access, adherence and tolerance of the potent drugs in 254 patients being treated at five urban sites in Boston and Rhode Island.

In one study, about 40 percent of 151 patients who tried one or more of the four available protease inhibitors eventually discontinued the drug. The most common reason patients gave was gastrointestinal and systemic side effects, followed by treatment failure, says lead author Valerie Stone, M.D., director of the Hope Center for HIV Care at Memorial Hospital in Pawtucket, R.I., and an assistant professor of medicine at Brown University.

"Patients can only benefit from protease inhibitors while they are taking the pills," Stone says. "If it turns out that regular patients in clinical practice aren't able to stick with the medications, they can't derive the benefits, such as increased survival and improved quality of life, that we've been led to expect." The take-home lesson is to optimize treatment regimens for individual patients and to closely manage side effects and toxicity, Stone says.

Despite the side effects and complex daily drug doses, most patients successfully adhere to their protease inhibitor therapy, except for those patients who have active substance abuse or alcohol problems, says another study Stone will present Wednesday, July 1.

Although they can stick to treatment, women, minorities and patients with less education are less likely to be offered potent drug cocktails containing protease inhibitors, according to another paper by Stone and colleagues to be given Thursday, July 2. "While combination regimens containing protease inhibitors can dramatically improve outcomes, not all patients who can benefit are receiving them
'"/>

Contact: Carol Cruzan Morton
carol_morton@brown.edu
401.863.2476
Brown University
30-Jun-1998


Page: 1 2

Related medicine news :

1. X-Rays: How Big A Risk To Kids? UF Researchers Seek Answers
2. Study Shows Child Health Plus Eases Access, But Some Barriers Remain
3. Tolerance for alcohol associated with family history
4. Teen Line Panel Of Six High School Students To Address The Issue Of Teens And Tolerance
5. Protease inhibitor could help prevent alzheimers
6. New Protease Inhibitor Could Thwart AIDS Resistance To Current Drugs
7. HIV Patients Treated With Protease Inhibitors Are More Likely To Engage In Risky Sex, Emory Researchers Report
8. Only Eight Percent Of San Francisco HIV-Positive Urban Poor Receive Protease Inhibitors
9. Declining National Rates Of HIV-Related Deaths And Illnesses Due To Combination Antiretroviral Therapy With Protease Inhibitors
10. Inhibitors prevent aggresome formation associated with some forms of ALS
11. Acetylcholinesterase Inhibitors May Be Another Piece In Alzheimers Jigsaw

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/16/2018)... ... November 16, 2018 , ... ... of a new corridor from Canada to India. The marketplace currently offers money ... the Canadian International Development Platform, in 2016, an estimated $23.3 billion was sent ...
(Date:11/16/2018)... ... 2018 , ... Opioid drugs are commonly prescribed for back pain and other chronic pain. They ... signals. The problem with these drugs, however, is that they are very addictive. In fact, ... and 2017, more than 130 people per day died as a result of opioid drug ...
(Date:11/15/2018)... ... November 15, 2018 , ... Modern Acupunctureâ„¢, the first ... people in an accessible and affordable delivery, is now open in Bothell. Modern ... locations all across the country. , Located at 1427 228th Street in the ...
(Date:11/15/2018)... ... November 15, 2018 , ... Sift Healthcare, ... Seed Fund and additional investors including Wind River Financial, a Madison-based payment processing ... partnership with Wind River to provide a range of solutions for healthcare organizations ...
(Date:11/15/2018)... ... November 15, 2018 , ... Drs. Randolph ... skilled medical professionals to join their team at Waldman, Schantz, Turner ... clinic, Skin Chic, and is expanding its staff to meet patient demand. These ...
Breaking Medicine News(10 mins):
(Date:11/15/2018)... ... November 15, 2018 , ... ... and reconstructive surgery in their lives will soon be able to access a ... of work, Alton Ingram, MD, created the now-popular blog website http://www.draltoningrammd.com/ ...
(Date:11/15/2018)... , ... November 15, 2018 , ... ... data, today announced that the company has been awarded a $225,000 Phase I ... the National Institutes of Health (NIH). , The pursuit of useful, well-structured data ...
(Date:11/15/2018)... (PRWEB) , ... November 15, ... ... the acquisition of Metamorphosis, an Opioid Treatment Program (OTP) with locations in ... since 1995, Metamorphosis has established themselves as a high-quality, trusted provider of ...
Breaking Medicine Technology:
Cached News: